Sprint Bioscience AB Market Cap

Sprint Bioscience AB has a market cap or net worth of 331.32 million as of April 28, 2026. Its market cap has increased by 587.73% in one year.

Market Cap

331.32M

Enterprise Value

204.61M

Revenue

167.39M

Ranking

n/a

PE Ratio

3.20

Stock Price

3.14

Market Cap Chart

Since November 7, 2014, Sprint Bioscience AB's market cap has increased from 62.49M to 331.32M, an increase of 430.16%. That is a compound annual growth rate of 15.64%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	328.15M	111.56%
Dec 30, 2025	155.11M	40.43%
Dec 30, 2024	110.46M	-8.82%
Dec 29, 2023	121.14M	449.78%
Dec 30, 2022	22.03M	-88.47%
Dec 30, 2021	191.05M	17.26%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Bio-Works Technologies AB	317.16M
Mendus AB	300.61M
Ascelia Pharma AB	399.64M
Xintela AB	238.57M
Corline Biomedical AB	411.10M
Intervacc AB	412.38M
Isofol Medical AB	222.74M
Initiator Pharma	214.26M

Market Cap Rankings